From the reviews:

“It is designed as an overview of the role of biotechnology in current cardiovascular therapies as well as an outline of future directions. The target audience is anyone interested in the field of biotechnology as it relates to cardiovascular medicine including physicians, scientists, engineers, and pharmacists. … This book is extremely well researched and clearly written by an authority in the field. This comprehensive overview of biotechnologies used in cardiovascular disease is an excellent resource for those interested in the development of new therapies.” (Geoffrey F. Lewis, Doody’s Book Reviews, January, 2012)

For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics 2011th Edition serves as an invaluable reference by collecting the essential writings of Dr. Kewal K. Jain on the topics of biotechnology as they relate to cardiovascular disease. This thorough volume includes such subjects as biotechnology and therapeutic delivery to the cardiovascular system, cell-selective targeted drug delivery, cell and gene therapies, including antisense and RNA interference, cutting-edge gene therapy approaches, as well as personalized cardiology as a way of integrating new technologies into the selection of the best possible treatment for an individual patient. Selected references from recent literature are collected for each chapter, and the text is supplemented by a variety of useful tables and figures.

Comprehensive and up-to-date, Applications of Biotechnology in Cardiovascular Therapeutics 2011th Edition will be tremendously useful for those working in life sciences and the pharmaceutical sciences, and the inclusion of some basics of cardiovascular diseases will greatly benefit nonmedical readers as well.

From the reviews:

“It is designed as an overview of the role of biotechnology in current cardiovascular therapies as well as an outline of future directions. The target audience is anyone interested in the field of biotechnology as it relates to cardiovascular medicine including physicians, scientists, engineers, and pharmacists. … This book is extremely well researched and clearly written by an authority in the field. This comprehensive overview of biotechnologies used in cardiovascular disease is an excellent resource for those interested in the development of new therapies.” (Geoffrey F. Lewis, Doody’s Book Reviews, January, 2012)

For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics 2011th Edition serves as an invaluable reference by collecting the essential writings of Dr. Kewal K. Jain on the topics of biotechnology as they relate to cardiovascular disease. This thorough volume includes such subjects as biotechnology and therapeutic delivery to the cardiovascular system, cell-selective targeted drug delivery, cell and gene therapies, including antisense and RNA interference, cutting-edge gene therapy approaches, as well as personalized cardiology as a way of integrating new technologies into the selection of the best possible treatment for an individual patient. Selected references from recent literature are collected for each chapter, and the text is supplemented by a variety of useful tables and figures.

Comprehensive and up-to-date, Applications of Biotechnology in Cardiovascular Therapeutics 2011th Edition will be tremendously useful for those working in life sciences and the pharmaceutical sciences, and the inclusion of some basics of cardiovascular diseases will greatly benefit nonmedical readers as well.